ReCellTis
- Product NDC
- 71929-070
- 11-digit product format
- 719290070
- Labeler code
- 71929
- Product ID
- 71929-070_d28337a3-e5f0-a89d-e053-2995a90a5ec5
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- bacitracin zinc, neomycin sulfate, polymyxin b sulfate, lidocaine HCl
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- CellNovation Technology
- Application
- part333B
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2019-06-01
- Marketing end
- 0000-00-00
- Substance
- LIDOCAINE; POLYMYXIN B SULFATE; BACITRACIN ZINC; NEOMYCIN SULFATE
- Active strength
- 600 mg/30g; [USP'U]/30g; [USP'U]/30g; mg/30g
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71929-070-28 | ReCellTisWound Cream | 28 g in 1 TUBE | CREAM | 28 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71929-070 | RECELLTIS WOUND CREAM (BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, LIDOCAINE HCL) CREAM [CELLNOVATION TECHNOLOGY] | 3 | Legacy NDC, 1 package rows | 20211207_8902aa55-547d-787f-e053-2a95a90a2289.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71929-070-28 | 71929007028 | 28 g in 1 TUBE (71929-070-28) | 28 g | 2019-10-01 | 0000-00-00 | No | No | Current |